Free product worth Rs 499 on all myUpchar products
Olmat 40 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of High BP. The alternative uses of Olmat 40 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Olmat 40 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Olmat 40 Tablet include Upper respiratory tract infection. Apart from the aforementioned side effects, Olmat 40 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Olmat 40 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Olmat 40 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Olmat 40 Tablet's effects on the liver, heart and kidney are discussed below in the Olmat 40 Tablet related warnings section.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension) must refrain from the use of Olmat 40 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Olmat 40 Tablet contraindications section.
Drug reaction of Olmat 40 Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Olmat 40 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Olmat 40 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Olmat 40 Tablet safe for pregnant women?
Olmat shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Olmat 40 Tablet safe during breastfeeding?
Breastfeeding women can take Olmat as it bears very minor side effects for them.
What is the effect of Olmat 40 Tablet on the Kidneys?
Olmat rarely harms the kidneys.
What is the effect of Olmat 40 Tablet on the Liver?
Olmat has very mild side effects on the liver.
What is the effect of Olmat 40 Tablet on the Heart?
Olmat has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Olmat 40 Tablet unless your doctor advises you to do so -
Is this Olmat 40 Tablet habit forming or addictive?
Forming a habit of Olmat 40 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Olmat 40 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but take Olmat 40 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Olmat 40 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Olmat 40 Tablet
When consumed with certain foods, Olmat 40 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Olmat 40 Tablet
Consuming Olmat 40 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
